期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
头电针治疗帕金森病疗效研究 被引量:20
1
作者 钱浩 吴强 +2 位作者 何伟 冉守连 林涛 《中华中医药杂志》 CAS CSCD 北大核心 2015年第7期2538-2540,共3页
目的:探讨头电针治疗对帕金森病(PD)患者睡眠、运动及用药剂量的影响。方法:70例接受头电针治疗的PD患者于治疗前及治疗6周后分别应用帕金森病睡眠量表(PDSS-CV)评价其睡眠、统一帕金森病评定量表第三部分(UPDRSⅢ)和Hoehn-Yahr(H-Y)分... 目的:探讨头电针治疗对帕金森病(PD)患者睡眠、运动及用药剂量的影响。方法:70例接受头电针治疗的PD患者于治疗前及治疗6周后分别应用帕金森病睡眠量表(PDSS-CV)评价其睡眠、统一帕金森病评定量表第三部分(UPDRSⅢ)和Hoehn-Yahr(H-Y)分级评价运动功能,同时记录治疗前后的多巴胺类药物剂量变化,并对相关结果进行配对t检验。结果:头电针治疗6周后PDSS-CV总分较治疗前有明显增加(P<0.05),其中问题1睡眠质量、问题2入睡困难和问题12肌张力障碍均较治疗前改善明显(P<0.05);"关"状态下UPDRSⅢ及H-Y分级均较治疗前有明显减轻(P<0.05);治疗后多巴胺类药物减少20.4%(P<0.05)。结论:头电针治疗除可明显改善PD患者的运动功能外,对非运动症状如睡眠障碍也有改善作用。 展开更多
关键词 帕金森病 头电针 睡眠 运动症状 pdss-cv
原文传递
脑康泰胶囊联合普拉克索治疗早期帕金森病的临床研究 被引量:5
2
作者 闫淳 李宝柱 +1 位作者 刘京锋 李博 《现代药物与临床》 CAS 2022年第8期1754-1759,共6页
目的探讨脑康泰胶囊联合普拉克索治疗早期帕金森病的临床效果。方法选取2019年4月—2021年10月北京市和平里医院收治的136例早期帕金森病患者,采用随机数字表法将所有患者平均分为对照组和治疗组,每组各68例。对照组口服盐酸普拉克索片... 目的探讨脑康泰胶囊联合普拉克索治疗早期帕金森病的临床效果。方法选取2019年4月—2021年10月北京市和平里医院收治的136例早期帕金森病患者,采用随机数字表法将所有患者平均分为对照组和治疗组,每组各68例。对照组口服盐酸普拉克索片,起始剂量0.125 mg/次,3次/d,随后根据患者耐受情况逐渐增加剂量,每周加量1次,每次日剂量增加0.375 mg,有效剂量为0.50~0.75 mg/次,3次/d,最大日剂量为4.5 mg。治疗组在对照组基础上口服脑康泰胶囊,3粒/次,3次/d。两组疗程均为12周。观察两组的临床疗效,比较治疗前后两组国际运动障碍学会帕金森病综合评定量表(MDSUPDRS)中各部分(Ⅰ、Ⅱ、Ⅲ、Ⅳ)评分及其总分、帕金森病睡眠评估量表中文版(PDSS-CV)总分、39项帕金森病生活质量问卷(PDQ-39)总分及血清白细胞介素(IL)-1β、IL-17、超氧化物歧化酶(SOD)、谷氨酸(Glu)和γ氨基丁酸(GABA)水平。并统计两组不良反应情况。结果治疗后,治疗组有效率是94.12%,较对照组82.35%显著提高(P<0.05)。治疗后,两组MDS-UPDRS中各部分(Ⅰ、Ⅱ、Ⅲ、Ⅳ)评分及其总分比治疗前均显著降低(P<0.05);且均以治疗组下降更显著(P<0.05)。治疗后,两组PDSS-CV总分比治疗前均显著升高,PDQ-39总分比治疗前均显著降低(P<0.05);且均以治疗组改善更显著(P<0.05)。治疗后,两组血清IL-1β、IL-17水平均显著低于治疗前,血清SOD、Glu和GABA水平均显著高于治疗前(P<0.05);且治疗后,治疗组血清IL-1β、IL-17水平比对照组均显著更低,血清SOD、Glu和GABA水平比对照组均显著更高(P<0.05)。治疗后,治疗组患者不良反应发生率是14.71%,比对照组29.41%显著降低(P<0.05)。结论脑康泰胶囊联合普拉克索治疗早期帕金森病的整体疗效满意,可安全有效地改善患者睡眠状况,并能进一步抑制血清IL-1β和IL-17表达水平、增强体内SOD活性及提高血清Glu、GABA水平,从而对患者生活质量及病情的改善具有重要作用。 展开更多
关键词 脑康泰胶囊 盐酸普拉克索片 帕金森病 帕金森病睡眠评估量表中文版(pdss-cv)总分 超氧化物歧化酶
原文传递
Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson’s disease
3
作者 Hongyan Zhou Cunzhou Shen +6 位作者 Jie Chen Hao Qian Yifan Zheng Yanmei Liu Wenbiao Xian Zhong Pei Ling Chen 《Translational Neurodegeneration》 SCIE CAS 2014年第1期148-154,共7页
Objective:To study the relationship between sleep disturbances and symptoms in patients with Parkinson’s disease(PD).Methods:The Parkinson’s Disease Sleep Scale-Chinese Version(PDSS-CV)was used to evaluate the sleep... Objective:To study the relationship between sleep disturbances and symptoms in patients with Parkinson’s disease(PD).Methods:The Parkinson’s Disease Sleep Scale-Chinese Version(PDSS-CV)was used to evaluate the sleep disturbances of PD patients in a cross sectional study.The Unified Parkinson’s Disease Rating Scale(UPDRS)parts II-IV,and the Hoehn&Yahr(H&Y)stage were used to determine the level of motor function in PD and the severity of PD.The Spearman correlation and a multiple regression analysis were used to identify the relationship between sleep disturbances and symptoms of PD.The quantities derived from the UPDRS and the H&Y stage and disease duration were compared between groups of patients either with or without sleep disturbances identified by the PDSS.This study was conducted from December 2011 to March 2012 at the First Affiliated Hospital of Sun Yat-sen University,in Guangzhou.Results:A total of 136 PD patients were included in this study.The overall total PDSS score in PD patients was 107.58±23.35 points(range:30–146).There were significant differences in the disease duration,the H&Y stage,and the UPDRS section subscores between groups of patients either with or without sleep disturbances(Kruskal-Wallis Test,p<0.05).There were significant negative correlations between PDSS scores and the UPDRS subscores,the H&Y stage and the disease duration(Spearman correlation,p<0.05).The multiple regression analysis indicated that sleep disturbances identified by the PDSS were only associated with daily life activity,tremor intensity and clinical fluctuation(R2=0.22,F(3,132)=12.4,p<0.001).The correlations were also significant when the contribution of the other two factors was excluded using partial correlations.Conclusions:The level of daily life activity and the occurrences of tremor and clinical fluctuation are likely to be important factors that lead to PD patients’sleep disturbances.This study may elucidate an important clue for the relationship between sleep disturbances and PD symptoms. 展开更多
关键词 Sleep disorders Parkinson’s disease Parkinson’s disease sleep scale-Chinese Version(pdss-cv) Unified Parkinson’s Disease Rating Scale(UPDRS)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部